News & Updates

$QoL preserved in patients with refractory mCRC treated with add-on bevacizumab$

QoL preserved in patients with refractory mCRC treated with add-on bevacizumab

26 Aug 2023 by

In the treatment of refractory metastatic colorectal cancer (mCRC), the addition of bevacizumab to trifluridine/tipiracil (FTD/TPI) does not appear to hurt the quality of life (QoL), with patients receiving add-on bevacizumab being able to maintain their QoL for a longer period than those receiving FTD/TPI monotherapy, according to a post hoc analysis of the phase III SUNLIGHT trial.

QoL preserved in patients with refractory mCRC treated with add-on bevacizumab

26 Aug 2023

Cold vs hot snare polypectomy: Which method is better for colorectal polyps?

26 Aug 2023

Hot snare polypectomy (HSP) tends to result in higher complete resection and lower recurrence rates, but a greater incidence of adverse events, compared with cold snare polypectomy (CSP), according to a study.

Cold vs hot snare polypectomy: Which method is better for colorectal polyps?

26 Aug 2023

Early cholecystectomy must be carefully considered in acute biliary pancreatitis

26 Aug 2023

Older and more fragile patients who present with severe complications associated with acute biliary pancreatitis (ABP) may not be the best candidates for early cholecystectomy, real-life data from the MANCTRA-1* study.

Early cholecystectomy must be carefully considered in acute biliary pancreatitis

26 Aug 2023

Intra-arterial gemcitabine bumps up survival in locally advanced pancreatic cancer

25 Aug 2023 by

In patients with locally advanced pancreatic cancer, treatment with intra-arterial gemcitabine leads to better survival and safety outcomes compared with standard-of-care therapy with intravenous gemcitabine/nab-paclitaxel, according to the first interim analysis of the phase III TIGeR-PaC trial presented at ESMO GI 2023.

Intra-arterial gemcitabine bumps up survival in locally advanced pancreatic cancer

25 Aug 2023

Which is the best single-use duodenoscope in the market?

25 Aug 2023

A recent study comparing two commercially available single-use disposable duodenoscopes (SDD), Exalt and aScope Duodeno, reports comparable safety and efficacy.

Which is the best single-use duodenoscope in the market?

25 Aug 2023

Older age at first screening colonoscopy linked to higher risk of adenomas, CRC

25 Aug 2023

At a first screening colonoscopy, older patients are more likely to have a detection of adenomatous polyps and colorectal cancer (CRC), reveals a study.

Older age at first screening colonoscopy linked to higher risk of adenomas, CRC

25 Aug 2023

Topical COX inhibitor mitigates capecitabine-associated HFS in GI cancer patients

23 Aug 2023 by

Topical diclofenac gel significantly reduced the incidence of hand-foot syndrome (HFS) in patients with gastrointestinal (GI) cancer receiving capecitabine, according to findings from the exploratory subgroup analysis of the D-ToRCH* trial.

Topical COX inhibitor mitigates capecitabine-associated HFS in GI cancer patients

23 Aug 2023

Esophageal cancer: Proton outshines photon therapy in safety, efficacy

23 Aug 2023

In the treatment of patients with esophageal cancer, proton-based radiotherapy appears to yield better safety and efficacy outcomes including organs at risk (OARs) doses, toxicity, and prognosis when compared with photon therapy, according to a meta-analysis.

Esophageal cancer: Proton outshines photon therapy in safety, efficacy

23 Aug 2023

PPI exposure can make children susceptible to serious infections

17 Aug 2023

The use of proton pump inhibitors (PPIs) appears to pose heightened risks of serious infections in young children, according to a study.

PPI exposure can make children susceptible to serious infections

17 Aug 2023

Immunoscore predicts outcomes in localized colon cancer

15 Aug 2023 by

In patients with localized colon cancer, a low Immunoscore is indicative of poorer clinical outcomes, particularly disease-free and overall survival, suggest the results of a Philippines study presented at the recent ESMO GI 2023.

Immunoscore predicts outcomes in localized colon cancer

15 Aug 2023

News & Updates

Filter by Specialty:

Specialty:

QoL preserved in patients with refractory mCRC treated with add-on bevacizumab

QoL preserved in patients with refractory mCRC treated with add-on bevacizumab

Cold vs hot snare polypectomy: Which method is better for colorectal polyps?

Cold vs hot snare polypectomy: Which method is better for colorectal polyps?

Early cholecystectomy must be carefully considered in acute biliary pancreatitis

Early cholecystectomy must be carefully considered in acute biliary pancreatitis

Intra-arterial gemcitabine bumps up survival in locally advanced pancreatic cancer

Intra-arterial gemcitabine bumps up survival in locally advanced pancreatic cancer

Which is the best single-use duodenoscope in the market?

Which is the best single-use duodenoscope in the market?

Older age at first screening colonoscopy linked to higher risk of adenomas, CRC

Older age at first screening colonoscopy linked to higher risk of adenomas, CRC

Topical COX inhibitor mitigates capecitabine-associated HFS in GI cancer patients

Topical COX inhibitor mitigates capecitabine-associated HFS in GI cancer patients

Esophageal cancer: Proton outshines photon therapy in safety, efficacy

Esophageal cancer: Proton outshines photon therapy in safety, efficacy

PPI exposure can make children susceptible to serious infections

PPI exposure can make children susceptible to serious infections

Immunoscore predicts outcomes in localized colon cancer

Immunoscore predicts outcomes in localized colon cancer